Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis. | Transpl Int;21(11): 1102, 2008 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis.

Meyer, Tobias N; Thaiss, Friedrich; Stahl, Rolf A K.

Transpl Int ; 21(11): 1102, 2008 Nov.

Article in En | MEDLINE | ID: mdl-18564984

Subject(s)

Antibodies, Monoclonal/therapeutic use; Glomerulosclerosis, Focal Segmental/drug therapy; Antibodies, Monoclonal, Murine-Derived; Humans; Kidney Transplantation; Proteinuria/prevention & control; Rituximab; Secondary Prevention; Time Factors

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulosclerosis, Focal Segmental / Antibodies, Monoclonal Limits: Humans Language: En Journal: Transpl Int Journal subject: TRANSPLANTE Year: 2008 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulosclerosis, Focal Segmental / Antibodies, Monoclonal Limits: Humans Language: En Journal: Transpl Int Journal subject: TRANSPLANTE Year: 2008 Document type: Article